Afficher la couverture 'TRAIL: at the center of drugable anti-tumor pathways | Clarke, Nicole' en grand format
/5

0 avis

TRAIL: at the center of drugable anti-tumor pathways

Archive ouverte

Clarke, Nicole | Nebbioso, Angela | Altucci, Lucia | Gronemeyer, Hinrich

Edité par CCSD -

Molecular analysis, in vivo and in vitro has identified TRAIL as a central component of anti-cancer networks in the cell. More recently, TRAIL has been shown to be involved in the selective apoptosis of AML cells by histone deacetylase inhibitors (HDACi). Here we summarize findings that the TRAIL pathway is a key factor in the apoptotic action of HDACi, as well as, retinoids and retinoid-combinations.

Consulter en ligne

Suggestions

Du même auteur

TRAIL: at the center of drugable anti-tumor pathways.

Archive ouverte | Clarke, Nicole | CCSD

Molecular analysis, in vivo and in vitro has identified TRAIL as a central component of anti-cancer networks in the cell. More recently, TRAIL has been shown to be involved in the selective apoptosis of AML cells by histone deacet...

Acute myeloid leukemia: therapeutic impact of epigenetic drugs.

Archive ouverte | Altucci, Lucia | CCSD

International audience. Acute myeloid leukemia (AML) is not a single disease but a group of malignancies in which the clonal expansion of various types of hematopoietic precursor cells in the bone marrow leads to pe...

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.

Archive ouverte | Nebbioso, Angela | CCSD

International audience. Chromatin is a dynamic macromolecular structure epigenetically modified to regulate specific gene expression. Altered chromatin function can lead to aberrant expression of growth regulators a...

Chargement des enrichissements...